The prevalence and clinical relevance of 2R/2R TYMS genotype in patients with gastrointestinal malignancies treated with fluoropyrimidine-based chemotherapy regimens

The Pharmacogenomics Journal, Published online: 19 February 2021; doi:10.1038/s41397-021-00210-2The prevalence and clinical relevance of 2R/2R TYMS genotype in patients with gastrointestinal malignancies treated with fluoropyrimidine-based chemotherapy regimens

Source: The Pharmacogenomics Journal - February 19, 2021 Category: Drugs & Pharmacology Authors: Moh ’d Khushman Girijesh Kumar Patel Anu Singh Maharjan Gwendolyn A. McMillin Cindy Nelson Peter Hosein Ajay P. Singh Source Type: research